Matt Windsor

Matt Windsor

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Do we need to wear masks? (Yes.) When will I know which phase I’m in? What is UAB Healthcheck? Read answers to these and other questions posed during the May 22 re-entry town hall along with more than 70 other questions that couldn’t be answered live due to time constraints.

Assistant Professor Ellen Eaton, M.D., an infectious diseases specialist, is leading the Jefferson County health department’s effort to reach special populations.

An online platform gives UAB innovators a chance to find creative solutions to front-line challenges. Anyone can post a clinical problem — or volunteer to help solve one.

Virologist Kevin Harrod, Ph.D., is the institution’s resident expert on SARS viruses. His lab is handling biological validation for innovative drug-repurposing studies supported by the School of Medicine’s Urgent COVID-19 research fund.

Microbiologists Troy Randall and Frances Lund are building key proteins from several coronaviruses to study antibody cross-reactivity and other crucial questions in this project supported through UAB’s urgent COVID-19 research fund.

The director of UAB’s doctoral program in epidemiology shares what she loves about the field and her path into the profession.

Four UAB leaders shared how they guided their teams through crisis in a lively seminar.

Protecting workers’ vision has become more challenging as a diverse workforce stretches the definition of a “typical” face. UAB researchers are going 3D to keep employees safe.

In this project supported through UAB’s urgent COVID-19 research fund, Professor Randall Davis aims to identify antibodies that block SARS-CoV-2 from entering human cells — information that could guide convalescent plasma therapy and more.

In this project supported through UAB’s urgent COVID-19 research fund, Assistant Professor Benjamin Larimer, Ph.D., adapts his lab’s work on phage display — normally used to identify new cancer treatments — to overcome limitations of antibody and vaccine testing.

Page 36 of 49